Luc Cabel

22PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersRadiation therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 01, 2025
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.

Toulsie Ramtohul, Derek Lollivier, Justine Spriet

|Dec 02, 2024
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons.

Marc Michel, Maryam Heidary, Anissa Mechri

|Nov 29, 2024
Circulating tumor cells in breast cancer: clinical validity and utility.

Thibault Thomas-Bonafos, Jean Yves Pierga, François-Clément Bidard

|Sep 13, 2024
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group.

Alexander W Wyatt, Saskia Litiere, Francois-Clément Bidard

|Jun 25, 2024
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.

F Poumeaud, M Morisseau, L Cabel

|Feb 27, 2024
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis.

Antoine Vasseur, Luc Cabel, Caroline Hego

Pageof 4

Frequent Collaborators

10 joint publications

Francois-Clement Bidard

5 joint publications

William Jacot

3 joint publications

Anne Vincent-Salomon

3 joint publications

Jean-Yves Pierga